BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29964301)

  • 1. Immunohistochemical analysis of neutrophils, interleukin-17, matrix metalloproteinase-9, and neoformed vessels in oral squamous cell carcinoma.
    Silva RNF; Dallarmi LB; Araujo AKC; Alencar RCG; Mendonça EF; Silva TA; Batista AC; Costa NL
    J Oral Pathol Med; 2018 Oct; 47(9):856-863. PubMed ID: 29964301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical Expression of CD105 and TGF-β1 in Oral Squamous Cell Carcinoma and Adjacent Apparently Normal Oral Mucosa and its Correlation With Clinicopathologic Features.
    Nair S; Nayak R; Bhat K; Kotrashetti VS; Babji D
    Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):35-41. PubMed ID: 25710582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic relevance of CD105-assessed microvessel density in laryngeal carcinoma.
    Zvrko E; Mikic A; Vuckovic L; Djukic V; Knezevic M
    Otolaryngol Head Neck Surg; 2009 Oct; 141(4):478-83. PubMed ID: 19786216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating Anti-Matrix Metalloproteinase-7 Antibodies May Be a Potential Biomarker for Oral Squamous Cell Carcinoma.
    Jiang T; Xie P; Liu H
    J Oral Maxillofac Surg; 2016 Mar; 74(3):650-7. PubMed ID: 26454036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastasis-associated protein 1 expression in oral squamous cell carcinomas: correlation with metastasis and angiogenesis.
    Andishehtadbir A; Najvani AD; Pardis S; Ashkavandi ZJ; Ashraf MJ; Khademi B; Kamali F
    Turk Patoloji Derg; 2015; 31(1):9-15. PubMed ID: 25301048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum IL-17F combined with VEGF as potential diagnostic biomarkers for oral squamous cell carcinoma.
    Ding L; Hu EL; Xu YJ; Huang XF; Zhang DY; Li B; Hu QG; Ni YH; Hou YY
    Tumour Biol; 2015 Apr; 36(4):2523-9. PubMed ID: 25613064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ki67, CD105, and α-SMA Expression Supports Biological Distinctness of Oral Squamous Cell Carcinoma Arising in the Background of Oral Submucous Fibrosis.
    Gadbail AR; Korde S; Chaudhary MS; Sarode SC; Gondivkar SM; Dande R; Tekade SA; Yuwanati M; Hande A; Patil S
    Asian Pac J Cancer Prev; 2020 Jul; 21(7):2067-2074. PubMed ID: 32711434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary MMP-9 in the detection of oral squamous cell carcinoma.
    Peisker A; Raschke GF; Fahmy MD; Guentsch A; Roshanghias K; Hennings J; Schultze-Mosgau S
    Med Oral Patol Oral Cir Bucal; 2017 May; 22(3):e270-275. PubMed ID: 28160595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoglin expression is associated with poor oncologic outcome in oral and oropharyngeal carcinoma.
    Marioni G; Marino F; Giacomelli L; Staffieri C; Mariuzzi ML; Violino E; De Filippis C
    Acta Otolaryngol; 2006 Jun; 126(6):633-9. PubMed ID: 16720449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association and prognostic value of serum inflammation markers in patients with leukoplakia and oral cavity cancer.
    Chang PY; Kuo YB; Wu TL; Liao CT; Sun YC; Yen TC; Chan EC
    Clin Chem Lab Med; 2013 Jun; 51(6):1291-300. PubMed ID: 23154424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoglin (CD105) and microvessel density in oral squamous cell carcinoma.
    Mărgăritescu C; Simionescu C; Mogoantă L; Badea P; Pirici D; Stepan A; Ciurea R
    Rom J Morphol Embryol; 2008; 49(3):321-6. PubMed ID: 18758636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating CD105 shows significant impact in patients of oral cancer and promotes malignancy of cancer cells via CCL20.
    Chen CH; Chuang HC; Lin YT; Fang FM; Huang CC; Chen CM; Lu H; Chien CY
    Tumour Biol; 2016 Feb; 37(2):1995-2005. PubMed ID: 26334621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of vascularity as an index of angiogenesis in periradicular granulomas. Comparison with oral carcinomas and normal tissue counterparts.
    Davey KJ; Perrier S; Ohe G; Gilbert AD; Bankfalvi A; Saunders WP; Schor SL; Schor AM
    Int Endod J; 2008 Nov; 41(11):987-96. PubMed ID: 19133088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoglin (CD105) positive microvessel density and its relationship with lymph node metastasis in squamous cell carcinoma of the tongue.
    Eshghyar N; Mohammadi N; Rahrotaban S; Motahhary P; Vahedi Vaez SM
    Arch Iran Med; 2011 Jul; 14(4):276-80. PubMed ID: 21726105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of transforming growth factor beta 1 [TGF-β1] and matrix metalloproteinase 9 [MMP-9] in oral squamous cell carcinoma.
    Elahi M; Rakhshan V; Ghasemian NT; Moshref M
    Biomarkers; 2012 Feb; 17(1):21-7. PubMed ID: 22106837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoglin (CD105) expression in squamous cell carcinoma of the oral cavity.
    Schimming R; Marmé D
    Head Neck; 2002 Feb; 24(2):151-6. PubMed ID: 11891945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential infiltration of neutrophils in T1-T2 versus T3-T4 oral squamous cell carcinomas: a preliminary study.
    Caldeira PC; de Andrade Sousa A; de Aguiar MC
    BMC Res Notes; 2015 Oct; 8():569. PubMed ID: 26467671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenic factors in squamous cell carcinoma of the oral cavity: do they have prognostic relevance?
    Schimming R; Reusch P; Kuschnierz J; Schmelzeisen R
    J Craniomaxillofac Surg; 2004 Jun; 32(3):176-81. PubMed ID: 15113577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical evaluation of MMP-2, MMP-9 and CD31/microvascular density in squamous cell carcinomas of the floor of the mouth.
    Monteiro-Amado F; Castro-Silva II; Lima CJ; Soares FA; Kowalski LP; Granjeiro JM
    Braz Dent J; 2013; 24(1):3-9. PubMed ID: 23657405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma.
    de Vicente JC; Fresno MF; Villalain L; Vega JA; Hernández Vallejo G
    Oral Oncol; 2005 Mar; 41(3):283-93. PubMed ID: 15743691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.